Multicolor photoreactions of the red light–activated channelrhodopsin Chrimson

J Johannes Vierock (Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Neurosciences Research Center) J Joel C. D. Kaufmann (Institute of Biology, Biophysical Chemistry, Humboldt-Universität zu Berlin) L Lukas Faiß (Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Neurosciences Research Center) L Linda Tillert (Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Neurosciences Research Center) B Benjamin S. Krause (Institute of Biology, Experimental Biophysics, Humboldt-Universität zu Berlin) P Paul Fischer (Institute of Biology, Experimental Biophysics, Humboldt-Universität zu Berlin) T Thi Bich Thao Nguyen (Institute of Biology, Experimental Biophysics, Humboldt-Universität zu Berlin) D Dietmar Schmitz (Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Neurosciences Research Center) B Benjamin R. Rost (Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Neurosciences Research Center) F Franz Bartl (Institute of Biology, Biophysical Chemistry, Humboldt-Universität zu Berlin) P Peter Hegemann

Abstract

Channelrhodopsins are light-gated ion channels that are used in modern neurosciences for the precise control of cellular ion fluxes by light. With a peak absorption at 585 nm, Chrimson is the most red-shifted cation-conducting ChR. It is frequently employed in multicolor experiments alongside blue light–sensitive optogenetic tools and is so far the only light-gated ion channel successfully applied in human vision restoration. However, its photoresponses to different wavelengths have not been thoroughly characterized. In this study, we identify multiple interconvertible dark states of Chrimson with distinct absorption and photokinetic properties. Combining electrophysiology and spectroscopy with optogenetic experiments in neurons, we unveil that this dark state heterogeneity is based on distinct protonation dynamics of the counterion complex and alternative retinal isomerization. In neurons, prolonged red illumination reduces Chrimson’s red light sensitivity, which is reflected by a blue shift of the action spectrum. Blue light pulses reverse this shift and increase the excitability in subsequent red-light flashes. This understanding of wavelength-dependent photoreactions in Chrimson will improve the design of multicolor optogenetic experiments and inform strategies for optimizing Chrimson for therapeutic applications.

Article Details

Volume / Issue Vol. 122, Issue 52
Published December 30, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (11)

J

Johannes Vierock

Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Neurosciences Research Center

J

Joel C. D. Kaufmann

Institute of Biology, Biophysical Chemistry, Humboldt-Universität zu Berlin

L

Lukas Faiß

Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Neurosciences Research Center

L

Linda Tillert

Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Neurosciences Research Center

B

Benjamin S. Krause

Institute of Biology, Experimental Biophysics, Humboldt-Universität zu Berlin

P

Paul Fischer

Institute of Biology, Experimental Biophysics, Humboldt-Universität zu Berlin

T

Thi Bich Thao Nguyen

Institute of Biology, Experimental Biophysics, Humboldt-Universität zu Berlin

D

Dietmar Schmitz

Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Neurosciences Research Center

B

Benjamin R. Rost

Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Neurosciences Research Center

F

Franz Bartl

Institute of Biology, Biophysical Chemistry, Humboldt-Universität zu Berlin

P

Peter Hegemann